Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
Not Confirmed
Not Confirmed
17-21 January, 2026
Not Confirmed
Not Confirmed
21-22 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
Industry Trade Show
Not Confirmed
17-21 January, 2026
Industry Trade Show
Not Confirmed
21-22 January, 2026
Digital content

14 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/14/3218575/33240/en/Emergent-BioSolutions-Receives-U-S-FDA-Approval-on-Supplemental-New-Drug-Application-for-NARCAN-Nasal-Spray-to-be-Packaged-in-a-New-Carrying-Case-Making-Life-Saving-Naloxone-More-A.html

07 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/07/3214449/33240/en/Emergent-BioSolutions-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference-on-January-14-2026.html

12 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/12/3204634/33240/en/Emergent-BioSolutions-Receives-U-S-FDA-Approval-for-Drug-Product-Manufacturing-of-raxibacumab-at-its-Winnipeg-Canada-Site.html

18 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/18/3189947/33240/en/Emergent-BioSolutions-Marks-10-Year-Anniversary-of-the-U-S-FDA-Approval-of-NARCAN-Nasal-Spray-and-Reinforces-its-Commitment-to-Increasing-Naloxone-Access.html

12 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/12/3186739/33240/en/Emergent-BioSolutions-Announces-Retirement-of-Dr-Louis-W-Sullivan-from-Board-of-Directors.html

29 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/29/3176881/33240/en/Emergent-BioSolutions-Reports-Third-Quarter-2025-Financial-Results.html
Services
Drug Product Manufacturing
ABOUT THIS PAGE